Tekla Capital Management’s ResMed RMD Stock Holding History

Tekla Capital Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$7.58M	Sell	34,704 -38,485	-53%	-$8.58M	0.3%	67
2023 Q1	$16M	Buy	73,189 +12,490	+21%	+$2.71M	0.61%	40
2022 Q4	$12.6M	Hold	60,699	–	–	0.48%	50
2022 Q3	$13.3M	Sell	60,699 -10,300	-15%	-$2.34M	0.54%	44
2022 Q2	$14.9M	Hold	70,999	–	–	0.58%	45
2022 Q1	$17.2M	Sell	70,999 -3,600	-5%	-$871K	0.6%	46
2021 Q4	$19.4M	Buy	74,599 +60,410	+426%	+$15.7M	0.63%	44
2021 Q3	$3.74M	Sell	14,189 -123,618	-90%	-$33.8M	0.12%	116
2021 Q2	$34M	Buy	137,807 +5,463	+4%	+$1.15M	1.1%	24
2021 Q1	$25.7M	Hold	132,344	–	–	0.88%	27
2020 Q4	$28.1M	Buy	132,344 +35,275	+36%	+$7.03M	0.99%	28
2020 Q3	$16.6M	Buy	97,069 +79,238	+444%	+$14.6M	0.62%	40
2020 Q2	$3.42M	Hold	17,831	–	–	0.13%	127
2020 Q1	$2.63M	Sell	17,831 -9,944	-36%	-$1.58M	0.12%	120
2019 Q4	$4.3M	Sell	27,775 -9,335	-25%	-$1.35M	0.16%	118
2019 Q3	$5.01M	Sell	37,110 -15,000	-29%	-$1.97M	0.22%	83
2019 Q2	$6.36M	Sell	52,110 -16,864	-24%	-$1.87M	0.26%	81
2019 Q1	$7.17M	Buy	68,974 +10,344	+18%	+$1.07M	0.29%	74
2018 Q4	$6.68M	Hold	58,630	–	–	0.29%	70
2018 Q3	$6.76M	Hold	58,630	–	–	0.25%	83
2018 Q2	$6.07M	Buy	58,630 +24,811	+73%	+$2.51M	0.23%	87
2018 Q1	$3.33M	Buy	+33,819	New	+$3.2M	0.13%	111

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Tekla Capital Management's RMD Position: Q2 2023 in Review

Tekla Capital Management reduced its ResMed (RMD) stake by 53% in Q2 2023, selling an estimated $8.58M and leaving 34,704 shares worth $7.58M. The position accounts for 0.3% of the portfolio, ranked #67.

Tekla Capital Management first reported a position in RMD in Q1 2018 and has held it in 22 quarters since. The position peaked at $34M in Q2 2021. 732 funds tracked by Wall St. Rank hold RMD as of Q2 2023.

Tekla Capital Management held 34,704 shares of ResMed worth $7.58M as of Q2 2023.
Tekla Capital Management sold 38,485 ResMed shares in Q2 2023, an estimated $8.58M.
ResMed made up 0.3% of Tekla Capital Management's portfolio in Q2 2023, its #67 holding.
Tekla Capital Management first reported a position in ResMed in Q1 2018 and has held it in 22 quarters since.
Tekla Capital Management's ResMed position peaked at $34M in Q2 2021.
732 funds tracked by Wall St. Rank held ResMed as of Q2 2023.

Based on Tekla Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.